Case number 2020-1011
Sun Pharmaceutical Industries v. Saptalis Pharmaceuticals, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 2, 2020 | 41 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [40] filed by Appellants Sun Pharmaceutical Industries, Ltd. and Ranbaxy Signature, LLC. Each side shall bear its own costs. ISSUED AS A MANDATE: 06/02/2020. Service as of this date by the Clerk of Court. [698455] [JAL] [Entered: 06/02/2020 08:00 AM] (2) |
| Jun 1, 2020 | 40 | MOTION of Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd. to terminate appeal through voluntary dismissal pursuant to FRAP 42(b). Cases to be terminated: 20-1011. (Briefing suspended pursuant to FCR 31 pending resolution of the motion). [Consent: unopposed]. Service: 06/01/2020 by email. [698393] [20-1011] [Charles Klein] [Entered: 06/01/2020 05:29 PM] (5) |
| Apr 30, 2020 | 39 | **TEXT ONLY** ORDER granting motion to extend time to file brief [38] filed by Appellants Sun Pharmaceutical Industries, Ltd. and Ranbaxy Signature, LLC. The reply brief is due 06/01/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [691107] [JAL] [Entered: 04/30/2020 09:09 AM] (0) |
| Apr 29, 2020 | 38 | MOTION of Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd. to extend the time to 06/01/2020 to file the Appellant reply brief. [Consent: unopposed]. Service: 04/29/2020 by email. [690967] [20-1011] [Charles Klein] [Entered: 04/29/2020 02:49 PM] (6) |
| Apr 27, 2020 | 37 | MODIFIED ENTRY: RESPONSE BRIEF FILED for Appellee Saptalis Pharmaceuticals, LLC. Number of Pages: 54. Service: 04/27/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [690345] --[Edited 04/28/2020 by JAL - Compliance review complete] [Donald Mizerk] [Entered: 04/27/2020 04:07 PM] (69) |
| Apr 27, 2020 | 36 | MODIFIED ENTRY: CONFIDENTIAL RESPONSE BRIEF FILED for Appellee Saptalis Pharmaceuticals, LLC. Number of Pages: 54. Service: 04/27/2020 by email. [690343]--[Edited 04/28/2020 by JAL - Compliance review complete] [Donald Mizerk] [Entered: 04/27/2020 04:05 PM] (0) |
| Apr 7, 2020 | 35 | **TEXT ONLY** ORDER granting motion to extend time to file brief [34] filed by Appellee Saptalis Pharmaceuticals, LLC. The response brief is due 04/27/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [684642] [LMN] [Entered: 04/07/2020 09:15 AM] (0) |
| Apr 6, 2020 | 34 | MOTION of Appellee Saptalis Pharmaceuticals, LLC to extend the time to 04/27/2020 to file the Appellee's Response Brief. [Consent: unopposed]. Service: 04/06/2020 by email. [684588] [20-1011] [Donald Mizerk] [Entered: 04/06/2020 10:20 PM] (8) |
| Apr 1, 2020 | 33 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to withdraw attorney Docket No. [30], ERROR: Appellant's motion did not contain a certificate of compliance with the word/line count requirement. CORRECTION: For future motions, pursuant to FRAP 32(g), please include a certificate of compliance. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [683312] [JAL] [Entered: 04/01/2020 08:59 AM] (0) |
| Apr 1, 2020 | 32 | **TEXT ONLY** ORDER granting motion to withdraw Andrew C. Nichols as counsel [30] filed by Appellant Ranbaxy Signature, LLC. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [683310] [JAL] [Entered: 04/01/2020 08:57 AM] (0) |
| Mar 31, 2020 | 31 | Amended Entry of appearance for Claire A. Fundakowski as of counsel for Appellant Ranbaxy Signature, LLC. Service: 03/31/2020 by email. [683013] [20-1011] [Claire Fundakowski] [Entered: 03/31/2020 10:22 AM] (2) |
| Mar 31, 2020 | 30 | MOTION of Appellant Ranbaxy Signature, LLC to withdraw counsel Andrew C. Nichols [Consent: unopposed]. Service: 03/31/2020 by email. [683011] [20-1011] [Charles Klein] [Entered: 03/31/2020 10:20 AM] (4) |
| Mar 31, 2020 | 29 | Amended Entry of appearance for Charles B. Klein as principal counsel for Appellant Ranbaxy Signature, LLC. Service: 03/31/2020 by email. [683009] [20-1011] [Charles Klein] [Entered: 03/31/2020 10:17 AM] (2) |
| Mar 27, 2020 | 28 | ORDER filed granting [22] motion. ECF Nos. 23 and 24 are accepted for filing. Service as of this date by the Clerk of Court. [682275] [LMS] [Entered: 03/27/2020 10:39 AM] (2) |
| Mar 26, 2020 | 27 | ORDER granting motion to extend time to file appellee's response brief [25] filed by Appellee Saptalis Pharmaceuticals, LLC. Service as of this date by the Clerk of Court. [681839] [LMS] [Entered: 03/26/2020 07:36 AM] (2) |
| Mar 24, 2020 | 26 | Entry of appearance for Dustin L. Taylor as of counsel for Appellee Saptalis Pharmaceuticals, LLC. Service: 03/24/2020 by email. [681252] [20-1011] [Dustin Taylor] [Entered: 03/24/2020 09:18 AM] (2) |
| Mar 20, 2020 | 25 | MOTION of Don J. Mizerk Appellee Saptalis Pharmaceuticals, LLC to extend the time to 04/13/2020 to file the Appellee's Opening Brief. [Consent: unopposed]. Service: 03/20/2020 by email. [680669] [20-1011] [Donald Mizerk] [Entered: 03/20/2020 03:34 PM] (7) |
| Mar 17, 2020 | 24 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL OPENING BRIEF FILED for Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd. Number of Pages: 33. Service: 03/17/2020 by US mail. [679630]--[Edited 03/27/2020 by JAL - Accepted pursuant to order [28]] [Charles Klein] [Entered: 03/17/2020 06:32 PM] (0) |
| Mar 17, 2020 | 23 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED for Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd. Number of Pages: 33. Service: 03/17/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of the original version of this brief. See Fed. Cir. R. 31. [679628] --[Edited 03/27/2020 by JAL - Accepted pursuant to order [28]] [Charles Klein] [Entered: 03/17/2020 06:21 PM] (107) |
| Mar 17, 2020 | 22 | MOTION of Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd. For an Exception to the Confidentiality Requirements Under Circuit Rules 28(D) and 30(H) [Consent: unopposed]. Service: 03/17/2020 by email. [679617] [20-1011] [Charles Klein] [Entered: 03/17/2020 05:59 PM] (6) |
| Mar 10, 2020 | 21 | NOTICE OF NON-COMPLIANCE: The submissions of Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd., Corrected Opening Brief and Corrected Confidential Opening Brief [19], [20], are not in compliance with the rules of this court (see attached). Compliant documents are due on 03/17/2020. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [677681] [JAL] [Entered: 03/10/2020 05:30 PM] (2) |
| Feb 28, 2020 | 20 | FILED from Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd. Title: CORRECTED CONFIDENTIAL OPENING BRIEF. Service: 02/27/2020 by US mail. [675330] [20-1011] This document is non-compliant. See Doc No.[21] [Charles Klein] [Entered: 02/28/2020 05:35 PM] (0) |
| Feb 28, 2020 | 19 | FILED from Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd. Title: CORRECTED OPENING BRIEF. Service: 02/28/2020 by email. [675329] [20-1011] This document is non-compliant. See Doc No.[21] [Charles Klein] [Entered: 02/28/2020 05:32 PM] (107) |
| Feb 21, 2020 | 18 | NOTICE OF NON-COMPLIANCE: The submissions of Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd., Opening Brief and Confidential Opening Brief [16], [17], are not in compliance with the rules of this court (see attached). Compliant documents are due on 02/28/2020. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [673302] [JAL] [Entered: 02/21/2020 02:33 PM] (2) |
| Feb 18, 2020 | 17 | FILED from Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd. Title: CONFIDENTIAL OPENING BRIEF. Service: 02/18/2020 by US mail. [672166] [20-1011] This document is non-compliant. See Doc No.[18] [Charles Klein] [Entered: 02/18/2020 06:54 PM] (0) |
| Feb 18, 2020 | 16 | FILED from Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd. Title: OPENING BRIEF. Service: 02/18/2020 by email. [672165] [20-1011] This document is non-compliant. See Doc No.[18] [Charles Klein] [Entered: 02/18/2020 06:43 PM] (106) |
| Dec 3, 2019 | 15 | ORDER granting motion to extend time to file brief [12] filed by Appellants Sun Pharmaceutical Industries, Ltd. and Ranbaxy Signature, LLC. Appellants' opening brief is due no later than February 18, 2020. No further extensions should be anticipated. Service as of this date by the Clerk of Court. [653738] [LMS] [Entered: 12/03/2019 03:47 PM] (2) |
| Dec 2, 2019 | 14 | REPLY of Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd. to response [13]. Service: 12/02/2019 by email. [653083] [20-1011] [Claire Fundakowski] [Entered: 12/02/2019 10:39 AM] (5) |
| Nov 26, 2019 | 13 | RESPONSE of Appellee Saptalis Pharmaceuticals, LLC to the motion to extend time to file brief [12] filed by Appellants Sun Pharmaceutical Industries, Ltd. and Ranbaxy Signature, LLC. Service: 11/26/2019 by email. [652548] [20-1011] [Donald Mizerk] [Entered: 11/26/2019 02:20 PM] (8) |
| Nov 25, 2019 | 12 | MOTION of Appellants Sun Pharmaceutical Industries, Ltd. and Ranbaxy Signature, LLC to extend the time to 02/18/2020 to file the Appellants' Opening Brief. [Consent: opposed]. Service: 11/25/2019 by email. [652260] [20-1011] [Claire Fundakowski] [Entered: 11/25/2019 04:50 PM] (7) |
| Oct 21, 2019 | 11 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.3 to promptly submit an amended Entry of Appearance and/or update their contact information through the PACER Service Center as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [643539] [JAL] [Entered: 10/21/2019 03:15 PM] (0) |
| Oct 18, 2019 | 10 | Entry of appearance for Claire A. Fundakowski as of counsel for Appellants Sun Pharmaceutical Industries, Ltd. and Ranbaxy Signature, LLC. Service: 10/18/2019 by email. [643272] [20-1011] [Claire Fundakowski] [Entered: 10/18/2019 05:38 PM] (2) |
| Oct 18, 2019 | 9 | Entry of appearance for Andrew C. Nichols as of counsel for Appellants Sun Pharmaceutical Industries, Ltd. and Ranbaxy Signature, LLC. Service: 10/18/2019 by email. [643268] [20-1011] [Andrew Nichols] [Entered: 10/18/2019 05:07 PM] (2) |
| Oct 18, 2019 | 8 | Entry of appearance for Bryce C. Cooper as of counsel for Appellants Sun Pharmaceutical Industries, Ltd. and Ranbaxy Signature, LLC. Service: 10/18/2019 by email. [643267] [20-1011] [Bryce Cooper] [Entered: 10/18/2019 05:04 PM] (2) |
| Oct 18, 2019 | 7 | Docketing Statement for the Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd.. Service: 10/18/2019 by email. [643263] [20-1011] [Charles Klein] [Entered: 10/18/2019 04:59 PM] (3) |
| Oct 18, 2019 | 6 | Certificate of Interest for Appellants Sun Pharmaceutical Industries, Ltd. and Ranbaxy Signature, LLC. Service: 10/18/2019 by email. [643262] [20-1011] [Charles Klein] [Entered: 10/18/2019 04:57 PM] (3) |
| Oct 18, 2019 | 5 | Entry of appearance for Charles B. Klein as principal counsel for Appellants Ranbaxy Signature, LLC and Sun Pharmaceutical Industries, Ltd.. Service: 10/18/2019 by email. [643260] [20-1011] [Charles Klein] [Entered: 10/18/2019 04:51 PM] (2) |
| Oct 18, 2019 | 4 | Docketing Statement for the Appellee Saptalis Pharmaceuticals, LLC. Service: 10/18/2019 by email. [643063] [20-1011] [Donald Mizerk] [Entered: 10/18/2019 10:46 AM] (4) |
| Oct 18, 2019 | 3 | Certificate of Interest for Appellee Saptalis Pharmaceuticals, LLC. Service: 10/18/2019 by email. [643060] [20-1011] [Donald Mizerk] [Entered: 10/18/2019 10:44 AM] (3) |
| Oct 18, 2019 | 2 | Entry of appearance for Don J. Mizerk as principal counsel for Appellee Saptalis Pharmaceuticals, LLC. Service: 10/18/2019 by email. [643058] [20-1011] [Donald Mizerk] [Entered: 10/18/2019 10:43 AM] (2) |
| Oct 4, 2019 | 1 | Appeal docketed. Received: 10/02/2019. [640378]Entry of Appearance is due 10/18/2019. Certificate of Interest is due on 10/18/2019. Docketing Statement is due 10/18/2019. Appellant's brief is due 12/03/2019. [JAL] [Entered: 10/04/2019 02:16 PM] (21) |
